全部文献期刊学位论文会议报纸专利标准年鉴图书|学者科研项目
中外文文献  中文文献  外文文献
作者:Anne Katrin Berger , Georg Martin Haag ...
来源:[J].BMC Gastroenterology(IF 2.11), 2017, Vol.17 (1)Springer
摘要:Pancreatic cancer occurs more frequently in older patients, but these are underrepresented in the phase III clinical studies that established the current treatment standards. This leads to uncertainty regarding the treatment of older patients with potentially toxic but active reg...
作者:Anne Katrin Berger , Dirk Jäger
来源:[J].Onkopipeline, 2008, Vol.1 (2), pp.74-77Springer
摘要:Die Monotherapie mit Gemcitabin bildete lange Zeit die Standardbehandlung für Patienten mit fortgeschrittenem Adenokarzinom des Pankreas. In den letzten Jahren wurden aufgrund der nach wie vor äußerst schlechten Prognose der Erkrankung vermehrte Anstrengungen unternommen, im...
作者:Anne Katrin Berger , Thomas Herrmann
来源:[J].Onkopipeline, 2010, Vol.3 (1), pp.48-51Springer
摘要:Die Möglichkeiten in der Behandlung solider Tumoren haben sich im Verlauf der letzten Jahre um das Spektrum der zielgerichteten Tumortherapien („targeted therapies“) erweitert. Sowohl monoklonale Antikörper als auch „small molecules“ werden im klinischen Alltag inz...
作者:Anne Katrin Berger , Ulrich Abel ...
来源:[J].Pancreatology(IF 2.043), 2014, Vol.14 (3), pp.211-215Elsevier
摘要:Abstract(#br)Background(#br)Pancreatic cancer is mainly a disease of the elderly population, but clinical trials do not reflect this age distribution. Data on treatment strategies and outcome of older patients are limited. The aim of our study was to analyze safety and outco...
作者:Anne Katrin Berger , Karl Heinz Weiss ...
来源:[J].Journal of Computer Assisted Tomography(IF 1.582), 2018Wolters Kluwer
摘要:OBJECTIVE: The aim of this study was to investigate whether hepatobiliary-phase (HBP) flip-angle (FA) increase to 25° improves conspicuity of focal nodular hyperplasia (FNH) and enables HBP delay reduction. METHODS: This was a retrospective study of 23 patients with 46 FNHs....
作者:Anne Katrin Berger , Dirk Jger
来源:[J].Chinese-German Journal of Clinical Oncology, 2007, (02), pp.142-148CNKI
摘要:Single-agent Gemcitabine has been the standard treatment for advanced pancreatic adenocarcinoma in the past years. Due to the aggressive and often chemotherapy-refractory character of this malignancy, systemic treatment options still remain limited. Many combination therapies hav...
被引频次:-下载频次:8
作者:Anne Katrin Berger , Drik Jäger
来源:[J].The Chinese-German Journal of Clinical Oncology, 2007, Vol.6 (2), pp.142-148Springer
摘要:Abstract(#br)Single-agent Gemcitabine has been the standard treatment for advanced pancreatic adenocarcinoma in the past years. Due to the aggressive and often chemotherapy-refractory character of this malignancy, systemic treatment options still remain limited. Many combination ...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×